semaglutide affect thyroid Can Cause Issues? FDA Warnings and Safety Facts Comparative safety and side effects

We've flagged 2 risks for Eli Lilly

2019 Feb 15;49(1):84-91

Mounjaro is a type of drug called a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist

In people without diabetes Weight loss was greater : ~8 kg at 12 mg ~12 kg at 36 mg At higher doses, participants were: ~14 more likely to achieve 10% weight loss ~15 more likely to reach 15% weight loss This aligns with whats been seen with injectable GLP-1sbut now via an oral agent

(4 June 2021)

Personalized Injection Safety and Genetic Insights at PlexusDx While injection technique is universal, individual responses to semaglutide vary based on genetics and metabolism